Bluejay Diagnostics, Inc. Annual Operating Income (Loss) in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bluejay Diagnostics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2024.
  • Bluejay Diagnostics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$1.48M, a 37.8% increase year-over-year.
  • Bluejay Diagnostics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$7.17M, a 30.5% increase year-over-year.
  • Bluejay Diagnostics, Inc. annual Operating Income (Loss) for 2024 was -$7.17M, a 30.5% increase from 2023.
  • Bluejay Diagnostics, Inc. annual Operating Income (Loss) for 2023 was -$10.3M, a 10.7% decline from 2022.
  • Bluejay Diagnostics, Inc. annual Operating Income (Loss) for 2022 was -$9.32M, a 188% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$7.17M +$3.14M +30.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 -$10.3M -$993K -10.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 -$9.32M -$6.09M -188% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$3.23M -$2.03M -170% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 -$1.2M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.